{"id":"W4404048194","doi":"10.3389/fonc.2024.1437360","title":"Multidisciplinary Canadian consensus on the multimodal management of high-risk and radioactive iodine-refractory thyroid carcinoma","year":2024,"lang":"en","type":"review","venue":"Frontiers in Oncology","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"London Health Sciences Centre; University of Toronto; Université de Sherbrooke; Centre Hospitalier Universitaire de Sherbrooke; Toronto Western Hospital; Nova Scotia Cancer Centre; University of British Columbia; Princess Margaret Cancer Centre; University of Calgary; Centre Hospitalier de l’Université de Montréal; University of Alberta; University Health Network; Dalhousie University; BC Cancer Agency","funders":"Bayer Canada; EMD Serono; Genentech; BeiGene; Ipsen; Eisai; Sanofi; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb; GlaxoSmithKline","keywords":"Medicine; Thyroid carcinoma; Radiation therapy; Thyroid cancer; Multidisciplinary approach; Malignancy; Thyroid; Reimbursement; Radioactive iodine; Oncology; Refractory (planetary science); Disease; Intensive care medicine; Internal medicine; Health care","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002488267,0.0004491483,0.001847858,0.0006187249,0.00007006578,0.000007900764,0.0001543939,0.0003912484,0.00004637794],"category_scores_gemma":[0.00002492609,0.0002772703,0.0002634689,0.0002676891,0.0003223965,0.000009397307,0.000100944,0.000702657,0.00003207057],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002638808,"about_ca_system_score_gemma":0.0008254889,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02154052,"about_ca_topic_score_gemma":0.008642851,"domain_scores_codex":[0.9980425,0.0002906618,0.000510988,0.0006105918,0.0001570443,0.0003882138],"domain_scores_gemma":[0.9986756,0.0003093987,0.0002834055,0.0004808394,0.00002435363,0.0002264273],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001639992,0.0003598951,0.001783219,0.003681356,0.002133913,0.002833132,0.0003478623,0.000002169447,6.327311e-8,0.000634848,0.06853548,0.9195241],"study_design_scores_gemma":[0.002392374,0.001654161,0.004482947,0.005635284,0.005637773,0.0001002392,0.0009086494,0.00003795411,0.000001419191,0.0001307894,0.9787318,0.0002866703],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00220566,0.9854378,0.000003861677,0.0007813266,0.001424352,0.00233535,0.0003800832,0.00001969209,0.007411883],"genre_scores_gemma":[0.01166341,0.9841571,0.002073859,0.00005289305,0.0001203895,0.0005976768,0.00006027067,0.00009094916,0.001183387],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9192374,"threshold_uncertainty_score":0.9999679,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02571575498584898,"score_gpt":0.3205644199417361,"score_spread":0.2948486649558871,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}